Neuronetics (STIM) Long-Term Investments (2019 - 2026)
Neuronetics (STIM) reported Long-Term Investments of $108000.0 for Q1 2026, up 45.95% year-over-year from $74000.0 in Q1 2025, and up 10.2% quarter-over-quarter from $98000.0 in Q4 2025.
Neuronetics (STIM) Long-Term Investments (2019 - 2026) Analysis & Trends
Neuronetics (STIM) has 8 years of Long-Term Investments data on file, last reported at $108000.0 in Q1 2026.
- Long-Term Investments for Q1 2026 came in at $108000.0, up 45.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $108000.0 (up 45.95% YoY), and the FY2025 annual result was $98000.0, up 13.95% from the prior year.
- Long-Term Investments improved to $108000.0 in Q1 2026 per STIM's latest filing, from $98000.0 in the prior quarter.
- Over five years, Long-Term Investments peaked at $1.7 million in Q2 2022 and troughed at $74000.0 in Q1 2025.
- A 5-year average of $622764.7 and a median of $517000.0 in 2024 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2024 and 2026: Long-Term Investments slumped 86.99% in 2024, then jumped 45.95% in 2026.
- A 5-year view of Long-Term Investments shows it stood at $1.2 million in 2022, then plunged by 45.91% to $661000.0 in 2023, then sank by 86.99% to $86000.0 in 2024, then climbed by 13.95% to $98000.0 in 2025, then advanced by 10.2% to $108000.0 in 2026.
- Business Quant data shows STIM's Long-Term Investments at $108000.0 in Q1 2026, $98000.0 in Q4 2025, and $94000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 166.25 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Neuronetics | 2.40 Mn | -7.28 Mn | 16.15 Mn | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 98,000.00 |
| Sep 30, 2025 | 94,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 86,000.00 |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 268,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | 661,000.00 |
| Sep 30, 2023 | 700,000.00 |
| Jun 30, 2023 | 859,000.00 |
| Mar 31, 2023 | 989,000.00 |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 1.37 Mn |
| Dec 31, 2021 | 1.70 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 1.85 Mn |